StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex r&d expenses

Research and development expenses are spending on new products and technology.

Vaccinex's R&D Expenses for the twelve months ending Dec 31, 2024 was $12.55M, down 24.3% year over year. For fiscal 2024 it was $12.55M, down 24.3% from the year before. The highest annual figure on record is $25.67M in fiscal 2019.

Annual r&d expenses

PeriodPeriod endValueChange
FY2024Dec 31, 2024$12.55M-24.3%
FY2023Dec 31, 2023$16.57M+18.6%
FY2022Dec 31, 2022$13.98M-18.5%
FY2021Dec 31, 2021$17.16M-20.4%
FY2020Dec 31, 2020$21.55M-16.1%
FY2019Dec 31, 2019$25.67M+14.8%
FY2018Dec 31, 2018$22.35M+35.1%
FY2017Dec 31, 2017$16.55M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$2.13M-36.5%
Q3 FY2024Sep 30, 2024$3.17M-27.3%
Q2 FY2024Jun 30, 2024$3.86M-23.5%
Q1 FY2024Mar 31, 2024$3.38M-11.3%
Q4 FY2023Dec 31, 2023$3.36M-10.3%
Q3 FY2023Sep 30, 2023$4.36M+27.0%
Q2 FY2023Jun 30, 2023$5.05M+31.4%
Q1 FY2023Mar 31, 2023$3.81M+28.5%
Q4 FY2022Dec 31, 2022$3.74M-5.4%
Q3 FY2022Sep 30, 2022$3.43M-5.5%
Q2 FY2022Jun 30, 2022$3.84M-5.4%
Q1 FY2022Mar 31, 2022$2.97M-46.2%
Q4 FY2021Dec 31, 2021$3.95M-6.9%
Q3 FY2021Sep 30, 2021$3.63M-50.5%
Q2 FY2021Jun 30, 2021$4.06M-10.8%
Q1 FY2021Mar 31, 2021$5.51M+1.9%
Q4 FY2020Dec 31, 2020$4.25M-3.7%
Q3 FY2020Sep 30, 2020$7.33M+12.1%
Q2 FY2020Jun 30, 2020$4.56M-37.6%
Q1 FY2020Mar 31, 2020$5.41M-27.0%
Q4 FY2019Dec 31, 2019$4.41M-37.6%
Q3 FY2019Sep 30, 2019$6.54M+23.1%
Q2 FY2019Jun 30, 2019$7.30M+32.5%
Q1 FY2019Mar 31, 2019$7.41M+66.4%
Q4 FY2018Dec 31, 2018$7.07M+40.7%
Q3 FY2018Sep 30, 2018$5.31M+23.8%
Q2 FY2018Jun 30, 2018$5.51M+62.5%
Q1 FY2018Mar 31, 2018$4.45M–
Q4 FY2017Dec 31, 2017$5.03M–
Q3 FY2017Sep 30, 2017$4.29M–
Q2 FY2017Jun 30, 2017$3.39M–

More Vaccinex figures

See a number that looks wrong?